TOI logo

ONCOLOGY INSTITUTE INC/THE

TOINASDAQ
🏆 #2949 by market capUS Equity
$167.56▼ $11.91 (−7.11%)
Simulated price
🔔
Track TOI
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 7.1%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$513M
Small Cap
📈Revenue Growth (YoY)
+27.8%
High Growth
📊Gross Margin
10.8%
Thin
💵FCF Margin
-0.6%
Thin
⚖️P/S Ratio
0.9x
Cheap
Otter Score
64
Fair
No chart data available for TOI.

Trading Snapshot

Day Range
$166.53 – $170.75
52-Week Range
$2.32 – $7.05
Volume
$3.59B
Avg Volume
$4.76B
Shares Outstanding
100.0M
Next Earnings
Oct 21, 2026

Fundamentals Snapshot

Annual Revenue
$503M
Last Q Revenue
$161M
P/E Ratio
-18.3
P/S Ratio
0.9x
EPS (TTM)
$-0.04
Dividend Yield
0.00%
Dilution (1yr)
+1241.0%

Why Investors Own TOI

  • ✓High-growth profile — revenue up +25.4% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 34% gross margin and 4% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

TOI logo

ONCOLOGY INSTITUTE INC/THE

TOI
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$503M▲ +27.8% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
15.2%▲ +10.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$36M▼ −40.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$28M▼ −8.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.01B▲ +1241.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$70M▲ +$3M YoY
StockOtter · stockotter.space

About ONCOLOGY INSTITUTE INC/THE

The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physician care, integrated on-site infusion and medication dispensing facilities, and advanced clinical trial management. The institute also provides radiation therapy, specialized outpatient programs for stem cell transplants and transfusions, and robust patient support services. Furthermore, TOI is actively involved in operating palliative care initiatives and overseeing clinical trials. These services are specifically designed to meet the needs of adult and senior cancer patients. The company maintains a significant operational footprint with 67 clinic locations. The Oncology Institute was established in 2007 and is headquartered in Cerritos, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
64/100

Analyst Price Target

ⓘ
Average Target
$170.71
▲ +1.9% Upside
High Target$214.35
Low Target$141.95
Based on 16 analysts

Latest News & Updates

🚀
MarketWatch·2h ago

ONCOLOGY INSTITUTE INC/THE tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Reuters·5h ago

Analysts lift TOI price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
CNBC·1d ago

ONCOLOGY INSTITUTE INC/THE announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.